CSS
DGX icon

Cubist Systematic Strategies’s Quest Diagnostics DGX Stock Holding History

Cubist Systematic Strategies’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,600
Closed -$195K – 3700
2023
Q3 		$195K Hold
1,600
– – ﹤0.01% 2794
2023
Q2 		$225K Buy
+1,600
New +$221K ﹤0.01% 2763
2022
Q3 		– Sell
-3,100
Closed -$412K – 4478
2022
Q2 		$412K Buy
+3,100
New +$422K ﹤0.01% 3202

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cubist Systematic Strategies's DGX Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 4,683 shares — an estimated $646K sold.

Cubist Systematic Strategies first reported a position in DGX in Q2 2014 and held it in 30 quarters. The position peaked at $16.6M in Q3 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 4,683 Quest Diagnostics shares in Q1 2024, an estimated $646K.
  • Cubist Systematic Strategies first reported a position in Quest Diagnostics in Q2 2014 and held it in 30 quarters.
  • Cubist Systematic Strategies's Quest Diagnostics position peaked at $16.6M in Q3 2021.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.